Laboratory surveillance for wild and vaccine-derived polioviruses, January 2004-June 2005

    Insights

    The World Health Organization

    Area of Science:

    • Virology
    • Epidemiology
    • Public Health

    Background:

    • The World Health Organization (WHO) established a global network of 145 virology laboratories.
    • This network supports the Polio Eradication Initiative (PEI) through surveillance activities.

    Purpose of the Study:

    • To analyze stool and environmental samples for polioviruses.
    • To identify circulating wild polioviruses (WPVs) and vaccine-derived polioviruses (VDPVs).
    • To guide supplementary immunization activities (SIAs) and investigate viral genetic relationships.

    Main Methods:

    • Utilizing a surveillance system to detect at least one acute flaccid paralysis (AFP) case per 100,000 persons aged <15 years.
    • Collecting adequate stool samples from patients and environmental samples.
    • Analyzing samples in Global Polio Laboratory Network laboratories.

    Main Results:

    • Laboratory data were used to identify WPV and VDPV circulation.
    • Data informed targeted SIAs to interrupt transmission.
    • Genetic relationships among viral isolates were investigated.

    Conclusions:

    • The Global Polio Laboratory Network plays a crucial role in polio eradication efforts.
    • Laboratory surveillance is essential for detecting and responding to poliovirus circulation.
    • The network's performance is critical for achieving a polio-free world.

    Related Concept Videos

    Poliomyelitis01:17

    Poliomyelitis

    Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
    Arboviral Encephalitis01:25

    Arboviral Encephalitis

    Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
    Investigation of Disease Outbreaks01:23

    Investigation of Disease Outbreaks

    Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
    Vaccinations01:51

    Vaccinations

    Overview
    Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

    Transmission-based Precautions I: Contact, Enteric, and Droplets

    Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
    Contact Precautions:
    Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
    Vaccine Production01:23

    Vaccine Production

    Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...